Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - TOTAL CURRENT ASSETS
Total Current Assets VRDN - Viridian Therapeutics, Inc.
486 M
LAST VALUE
55.90%
2 YEAR CAGR
49.40%
5 YEAR CAGR
72.76%
10 YEAR CAGR